Published in Stroke on December 18, 2008
Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol (2007) 3.44
Letter by Tsuda regarding article, "Low plasma arginine:asymmetric dimethyl arginine ratios predict mortality after intracranial aneurysm rupture". Stroke (2013) 1.09
Sympathoinhibitory effect of diltiazem and prevention of aneurysm formation. Hypertension (2014) 1.08
Angiotensin-(1-7) and bradykinin in baroreceptor reflex sensitivity in hypertension. Hypertension (2012) 1.08
Roles of sex steroid hormones and nitric oxide in the regulation of sympathetic nerve activity in women. Hypertension (2013) 1.08
Hypoadiponectinemia and endogenous nitric oxide synthase inhibitor in hypertension. Hypertension (2013) 1.08
Role of hyperleptinemia in the regulation of blood pressure and cardiac function. Hypertension (2013) 1.06
Letter by Tsuda regarding article, "Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging". Stroke (2013) 1.06
Low serum adiponectin levels and endothelial dysfunction in childhood hypertension. Am J Hypertens (2013) 1.06
Membrane fluidity and hypertension. Am J Hypertens (2003) 0.85
Bone mineral density, blood pressure, and stroke in elderly women. Stroke (2003) 0.78
Inosine, calcium channels, and neuroprotection against ischemic brain injury. Stroke (2005) 0.78
Role of hyperglycemia and glutamate receptors in ischemic injury in acute cerebral infarction. Stroke (2006) 0.78
Role of estrogen and endothelium in migraine in young women. Stroke (2009) 0.77
Sex hormones and carotid atherosclerosis in the metabolic syndrome. Stroke (2005) 0.77
Role of estrogens in the regulation of membrane microviscosity. Circ Res (2004) 0.76
Neuropeptide Y and sympathetic nervous system in blood pressure regulation. Hypertension (2003) 0.76
Leukemia inhibitory factor relaxes arteries through endothelium-dependent mechanism. Biochem Biophys Res Commun (2002) 0.76
Neuroprotective effect of isoflurane and N-methyl-D-aspartate receptors in ischemic brain injury. Stroke (2010) 0.76
Regulatory mechanisms underlying decreased bone mineral density in women with essential hypertension. Am J Hypertens (2003) 0.75
Leptin, C-reactive protein, and nitric oxide production in healthy humans. Circulation (2004) 0.75
Letter by Tsuda regarding article "Endothelial activation in lacunar stroke subtypes". Stroke (2011) 0.75
Neuroprotective effects of MK-801 and catecholamine release in the central nervous system. Stroke (2004) 0.75
Sex hormones and membrane microviscosity in elderly women. Circulation (2004) 0.75
Statins and gender-related difference in endothelial function in cerebral small vessel disease. Stroke (2009) 0.75
Hyperinsulinemia, insulin receptor number, and membrane microviscosity of erythrocytes in essential hypertension. Am J Hypertens (2005) 0.75
Statins and nitric oxide production against ischemic stroke. Stroke (2008) 0.75
Hyperglycemia and hyperinsulinemia in circulatory disorder after subarachnoid hemorrhage. Stroke (2006) 0.75
Hyperinsulinemia and estrogen-deficiency as risk factors for stroke in women. Stroke (2004) 0.75
Calcitonin gene-related peptide and sympathetic nervous system in hypertension-induced renal damage. Hypertension (2005) 0.75
Insulin sensitivity and membrane microviscosity in hypertension. Am J Hypertens (2004) 0.75
Hyperinsulinemia, intracellular calcium, and membrane function in essential hypertension. Am J Hypertens (2003) 0.75
Hyperinsulinemia, hyperleptinemia, and nitric oxide in the regulation of membrane micoviscosity . Circulation (2004) 0.75
Leptin receptor and membrane microviscosity of erythrocytes in essential hypertension. Am J Hypertens (2006) 0.75
Insulin and membrane microviscosity of erythrocytes as risk factors for stroke. Stroke (2003) 0.75
Glucose metabolism, noradrenaline release, and MK-801 in intracerebral hemorrhage. Stroke (2005) 0.75
Surgical menopause, salt sensitivity, and NO bioavailability in women. Hypertension (2006) 0.75
Role of bradykinin and catecholamines in cerebral infarction and brain edema. Stroke (2009) 0.75
A new hormone therapy with drospirenone and NO production in postmenopausal women. Hypertension (2006) 0.75
C-reactive protein and nitric oxide production in ischemic stroke. Stroke (2009) 0.75
Interactions between melatonin and estrogen in the regulation of blood pressure in women. Am J Hypertens (2006) 0.75
Modulation of endothelial function by walnuts and sex hormones. Circulation (2004) 0.75
Asymmetric dimethylarginine and cerebrovascular disorders in humans. Stroke (2006) 0.75
Leptin and nitric oxide production against ischemic neuronal injury. Stroke (2007) 0.75
Homocysteine, vitamin B6, and endothelial dysfunction in circulatory disorders. Stroke (2004) 0.75
Aerobic exercise and circulatory dysfunction in resistant hypertension. Hypertension (2012) 0.75
Insulin, leptin, and membrane microviscosity in blood pressure regulation. Hypertension (2004) 0.75
Sex hormones and asymmetric dimethylarginine in transplant arteriosclerosis. Circulation (2004) 0.75
Letter by Tsuda regarding article, "Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study". Stroke (2011) 0.75
Hyperinsulinemia and membrane microviscosity of erythrocytes as risk factors for stroke in patients with impaired glucose tolerance. Stroke (2006) 0.75
Angiotensin AT2 receptor-mediated neuroprotection and nitric oxide-bioavailability in stroke. Stroke (2009) 0.75
Neuroprotective effects of leptin and nitric oxide against cerebral ischemia. Stroke (2009) 0.75
Bradykinin and catecholamines in cardiac dysfunction after cerebral ischemia. Stroke (2009) 0.75
Risk of fracture and bone mineral density in stroke. Stroke (2009) 0.75
Asymmetric dimethylarginine and hypertension in cerebral small vessel disease. Stroke (2007) 0.75
Estrogen and asymmetric dimethylarginine in postmenopausal women. Circulation (2004) 0.75
Serum homocysteine and endothelial dysfunction in circulatory disorders in women. Circulation (2004) 0.75
Glutamate receptors and presympathetic neuronal hyperactivity of the central nervous system in hypertension. Hypertension (2013) 0.75
Asymmetric dimethylarginine and circulatory disorders in postmenopausal women. Circulation (2004) 0.75
Sex hormones and stroke rehabilitation in men and women. Stroke (2007) 0.75
Angiotensin-(1-7) and bradykinin in norepinephrine release in the central nervous system of hypertension. Hypertension (2005) 0.75
Smoking, estrogen, and membrane microviscosity in women. Stroke (2004) 0.75
Role of leptin in regulating nitric oxide production and membrane microviscosity. Circulation (2004) 0.75
Asymmetric dimethylarginine and hypertension in carotid artery disease. Stroke (2009) 0.75
Insulin sensitivity, glucose metabolism, and membrane fluidity in hypertensive subjects. Circulation (2004) 0.75